BCL11B and acute myeloid leukemia: The comparison of gene expression profile from BCL11B+ and BCL11B- patients revealed downregulation of genes involved in the innate immune response, inflammatory response, leukocyte migration and cell adhesion, leukotriene metabolic pathways and response to oxidative stress in BCL11B+ AML patients.